Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

被引：1
|
作者：
Kambhampati, Swetha [1 ]
Mei, Matthew [2 ]
Chen, Lu [3 ]
Puverel, Sandrine [4 ]
Chen, Robert [1 ]
Popplewell, Leslie L. [5 ]
Nikolaenko, Liana [6 ]
Peters, Lacolle [4 ]
Armenian, Saro H. [7 ]
Kwak, Larry W. [8 ]
Rosen, Steve T. [9 ]
Forman, Stephen J. [10 ]
Herrera, Alex F. [11 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Med Ctr, Div Lymphoma, Duarte, CA USA
[3] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA
[7] City Hope Comprehens Canc Ctr, Dept Pediat, Duarte, CA USA
[8] City Hope Comprehens Canc Ctr, Duarte, CA USA
[9] City Hope Natl Med Ctr, Hematol & Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA
[10] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Stem Cell Transplantat, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA
[11] City Hope Comprehens Canc Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9418 / 9419
页数：2
相关论文
共 50 条
  • [1] Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
    Thiruvengadam, Swetha Kambhampati
    Mei, Matthew G.
    Chen, Lu
    Puverel, Sandrine
    Chen, Robert
    Popplewell, Leslie L.
    Nikolaenko, Liana
    Peters, Lacolle
    Armenian, Saro
    Kwak, Larry W.
    Rosen, Steven T.
    Forman, Stephen J.
    Herrera, Alex F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10):
  • [2] Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma
    Mei, Matthew
    Tsai, Ni-Chun
    Palmer, Joycelynne
    Armenian, Saro
    Chen, Robert
    Rosen, Steven
    Forman, Stephen
    Popplewell, Leslie
    Kwak, Larry
    Martin, Peter
    Maddocks, Kami
    Bond, David
    Herrera, Alex F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (08): : 537 - 542
  • [3] Phase II Study of Brentuximab Vedotin Plus Ibrutinib for Patients with Relapsed/Refractory Hodgkin Lymphoma
    Chen, Robert W.
    Palmer, Joycelynne M.
    Herrera, Alex Francisco
    Armenian, Saro H.
    Mei, Matthew
    Popplewell, Leslie
    Fueger, Abbey
    Qasim, Imran
    Stiller, Tracy
    Rosen, Steven T.
    Forman, Stephen J.
    Kwak, Larry W.
    BLOOD, 2017, 130
  • [4] BRENTUXIMAB VEDOTIN PLUS VIGEPP CHEMOTHERAPY FOR RELAPSED/REFRACTORY ADOLESCENT HODGKIN LYMPHOMA
    Tsaplina, N.
    Valiev, T.
    LEUKEMIA RESEARCH, 2022, 121 : S60 - S60
  • [5] Brentuximab vedotin for relapsed or refractory Hodgkin's lymphoma
    Chen, Runzhe
    Chen, Baoan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1729 - 1733
  • [6] Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
    Salihoglu, A.
    Elverdi, T.
    Karadogan, I.
    Paydas, S.
    Ozdemir, E.
    Erdem, G.
    Karadurmus, N.
    Akyol, G.
    Kaynar, L.
    Yegin, Z. A.
    Sucak, G.
    Ozkocaman, V.
    Topcuoglu, P.
    Ozcan, M.
    Birtas, E.
    Goker, H.
    Baslar, Z.
    Ferhanoglu, B.
    ANNALS OF HEMATOLOGY, 2015, 94 (03) : 415 - 420
  • [7] Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
    Siddiqi, Tanya
    Thomas, Sandra H.
    Chen, Robert
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 79 - 85
  • [8] Brentuximab vedotin treatment in patients with relapsed or refractory Hodgkin lymphoma
    Zsuzsa, Molnar
    Imre, Pinczes Laszlo
    Klara, Piukovics
    Ildiko, Istenes
    Krisztina, Wolf
    Zoltan, Csukly
    Arpad, Szomor
    Arpad, Illes
    Zsofia, Miltenyi
    ORVOSI HETILAP, 2017, 158 (41) : 1630 - 1634
  • [9] Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
    A. Salihoglu
    T. Elverdi
    I. Karadogan
    S. Paydas
    E. Ozdemir
    G. Erdem
    N. Karadurmus
    G. Akyol
    L. Kaynar
    ZA Yegin
    G. Sucak
    V. Ozkocaman
    P. Topcuoglu
    M. Ozcan
    E. Birtas
    H. Goker
    Z. Baslar
    B. Ferhanoglu
    Annals of Hematology, 2015, 94 : 415 - 420
  • [10] BRENTUXIMAB VEDOTIN FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY
    Ferhanoglu, B.
    Salihoglu, A.
    Elverdi, T.
    Karadogan, I.
    Ozdemir, E.
    Erdem, G.
    Karadurmus, N.
    Akyol, G.
    Kaynar, L.
    Yegin, A.
    Sucak, G.
    Ozkocaman, V.
    Topcuoglu, P.
    Ozcan, M.
    Birtas, E.
    Goker, H.
    Baslar, Z.
    Paydas, S.
    HAEMATOLOGICA, 2014, 99 : 675 - 676
12345